A phase I clinical trial of LOXO-305
Phase of Trial: Phase I
Latest Information Update: 01 Mar 2018
At a glance
- Drugs LOXO-305 (Primary)
- Indications B cell lymphoma
- Focus Adverse reactions
- 01 Mar 2018 According to a Loxo Oncology media release, initiation of this trial is expected in the second half of 2018.
- 09 Nov 2017 New trial record
- 02 Nov 2017 According to a Loxo Oncology media release, the company expects to initiate this study in 2018.